My bookmarksSign up free

Commission Implementing Regulation (EU) 2020/1821 Article 1

Commission Implementing Regulation (EU) 2020/1821 Article 1

Article 1

1.   Extract from Panax notoginseng and Astragalus membranaceus as specified in the Annex to this Regulation shall be included in the Union list of authorised novel foods established in Implementing Regulation (EU) 2017/2470. 2.   For a period of five years from the date of entry into force of this Regulation only the initial applicant: — Company: NuLiv Science, — Address: 1050 W. Central Ave., Building C, Brea, CA 92821, USA, is authorised to place on the market within the Union the novel food referred to in paragraph 1, unless a subsequent applicant obtains authorisation for that novel food without reference to the data protected pursuant to Article 2 of this Regulation or with the agreement of NuLiv Science. 3.   The entry in the Union list referred to in paragraph 1 shall include the conditions of use and labelling requirements laid down in the Annex to this Regulation.

Read the full instrument →

Other provisions in Commission Implementing Regulation (EU) 2020/1821

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 1 of Commission Implementing Regulation (EU) 2020/1821 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next